Table 1. Baseline characteristics.
Oregon | Minnesota | SMT 0 (n = 64) | SMT 6 (n=65) | SMT 12 (n = 64) | SMT 18 (n = 63) | All (n=256) | |
---|---|---|---|---|---|---|---|
Sociodemographic information | |||||||
Age (y) | 37 (12) | 45 (12) | 40 (12) | 40 (12) | 43 (13) | 42 (14) | 41 (13) |
Female | 95 (74.2%) | 87 (68.0%) | 48 (75.0%) | 45 (69.2%) | 45 (70.3%) | 44 (69.8%) | 182 (71.1%) |
White non-Hispanic | 104 (81.2%) | 110 (85.9%) | 53 (82.8%) | 58 (89.2%) | 51 (79.7%) | 52 (82.5%) | 214 (83.6%) |
Married or living together | 66 (51.6%) | 92 (71.9%) | 39 (60.9%) | 34 (52.3%) | 42 (65.6%) | 43 (68.3%) | 158 (61.7%) |
College graduate | 86 (67.2%) | 85 (66.4%) | 36 (56.2%) | 46 (70.8%) | 41 (64.1%) | 48 (76.2%) | 171 (66.8%) |
Household income < $40,000 | 62 (48.4%) | 24 (19.2%) | 20 (31.7%) | 30 (46.9%) | 18 (28.6%) | 18 (28.6%) | 86 (34.0%) |
Smoker | 11 (8.6%) | 10 (7.8%) | 6 (9.4%) | 5 (7.7%) | 5 (7.8%) | 5 (7.9%) | 21 (8.2%) |
Confidence in treatment success (expectations) | |||||||
Spinal manipulation (1–7 scale)* | 5.1 (1.1) | 5.0 (1.0) | 5.0 (1.1) | 5.0 (1.0) | 5.2 (1.2) | 5.1 (1.0) | 5.1 (1.1) |
Light massage ((1–7 scale)* | 4.8 (1.4) | 4.8 (1.2) | 4.9 (1.2) | 4.7 (1.3) | 4.9 (1.4) | 4.8 (1.4) | 4.8 (1.3) |
Difference (manipulation – light massage) | 0.3 (1.6) | 0.2 (1.2) | 0.1 (1.5) | 0.3 (1.4) | 0.4 (1.5) | 0.3 (1.3) | 0.3 (1.4) |
Physical activity (Minutes / day) | 86 (106) | 85 (120) | 95 (130) | 69 (85) | 69 (85) | 99 (143) | 85 (113) |
(Days / wk) | 5.4 (1.5) | 5.2 (1.7) | 5.3 (1.5) | 5.3 (1.6) | 5.4 (1.6) | 5.1 (1.7) | 5.3 (1.6) |
Previous care for CGH | |||||||
Chiropractic | 67 (52.3%) | 59 (46.1%) | 29 (45.3%) | 28 (43.1%) | 34 (53.1%) | 35 (55.6%) | 126 (49.2%) |
Massage | 60 (46.9%) | 46 (35.9%) | 27 (42.2%) | 23 (35.4%) | 31 (48.4%) | 25 (39.7%) | 106 (41.4%) |
Chiropractic or massage | 77 (60.2%) | 63 (49.2%) | 34 (53.1%) | 30 (46.2%) | 40 (62.5%) | 36 (57.1%) | 140 (54.7%) |
Headache and neck complaint | |||||||
Days with CGH ( last 4 wk) | 15.8 (6.7) | 15.3 (6.6) | 15.1 (6.3) | 15.2 (7.2) | 16.2 (6.9) | 15.8 (6.1) | 15.6 (6.6) |
Average CGH pain intensity (0–10 scale)† | 4.5 (1.1) | 4.5 (1.1) | 4.4 (1.0) | 4.4 (1.0) | 4.5 (1.1) | 4.7 (1.1) | 4.5 (1.1) |
CGH Duration (y) | 7.9 (8.0) | 6.7 (7.9) | 5.7 (6.4) | 8.1 (9.3) | 8.4 (8.5) | 6.9 (7.1) | 7.3 (7.9) |
CGH-related disability (36–78)† | 58.7 (4.6) | 56.1 (4.9) | 58.5 (4.6) | 56.0 (5.2) | 57.2 (5.1) | 57.9 (4.4) | 57.4 (4.9) |
Lost work due to CGH | |||||||
1/2 day or more | 69 (53.9%) | 36 (28.1%) | 25 (38.5%) | 26 (40.6%) | 27 (42.9%) | 69 (53.9%) | 105 (41.0%) |
If yes, days with lost work (last 4 wk) | 2.0 (3.7) | 1.2 (4.3) | 1.4 (3.7) | 1.7 (4.6) | 1.8 (4.1) | 1.4 (3.8) | 1.6 (4.1) |
Days with non-CGH headaches (last 4 wk) | 2.3 (2.7) | 2.3 (3.0) | 2.3 (3.1) | 2.4 (3.0) | 2.3 (2.4) | 2.2 (3.1) | 2.3 (2.9) |
Days with neck pain (last 4 wk) | 18.8 (7.2) | 17.9 (7.8) | 19.2 (7.6) | 18.8 (7.2) | 18.2 (8.0) | 17.1 (7.3) | 18.3 (7.5) |
Average neck pain intensity (0–10 scale)† | 4.6 (1.5) | 4.6 (1.5) | 4.5 (1.5) | 4.5 (1.4) | 4.5 (1.5) | 4.8 (1.5) | 4.6 (1.5) |
Health Status | |||||||
Tension Type Headache | 30 (23.4%) | 23 (18.0%) | 14 (21.9%) | 13 (20.0%) | 13 (20.3%) | 13 (20.6%) | 53 (20.7%) |
Migraine | 31 (24.2%) | 25 (19.5%) | 14 (21.9%) | 15 (23.1%) | 14 (21.9%) | 13 (20.6%) | 56 (21.9%) |
Lower back problems | 43 (33.6%) | 43 (33.6%) | 19 (29.7%) | 20 (30.8%) | 22 (34.4%) | 25 (39.7%) | 86 (33.6%) |
Any back problems‡ | 70 (54.7%) | 70 (54.7%) | 37 (57.8%) | 32 (49.2%) | 35 (54.7%) | 36 (57.1%) | 140 (54.7%) |
Any comorbidity‡ | 90 (70.3%) | 87 (68.0%) | 45 (70.3%) | 39 (60.0%) | 49 (76.6%) | 44 (69.8%) | 177 (69.1%) |
EuroQol “Health State Today” (0–100 VAS)† | 74.4 (13.7) | 76.7 (13.2) | 74.9 (13.7) | 76.3 (11.3) | 76.1 (13.9) | 74.8 (15.0) | 75.5 (13.5) |
Days taking medication for CGH (last 4 wk) | 6.3 (4.9) | 6.3 (4.6) | 5.6 (4.5) | 5.9 (4.0) | 6.6 (5.4) | 7.0 (4.8) | 6.3 (4.7) |
SMT, spinal manipulative therapy; CGH, cervicogenic headache; VAS, visual analog scale.
Values are mean (standard deviation) or number (percentage).
Seven-point Likert scale from extremely doubtful (1) to extremely confidence (7) in treatment success.
Lower scores are more favorable with the exception of the EuroQol VAS.
Any back problems includes upper, middle, and lower back. Comorbidity includes any of the following: diabetes or arthritis, back, lung, cardiovascular, gastrointestinal, urinary, gynecological, or prostate problems.